Table 2 CT features in sixty-seven patients with SARS-CoV-2

Peripheral/central lesions

50 (92.6%) peripheral; 4 (7.4%) central

Lesions in middle upper/lower lobes

12 (22.2%) upper lobe; 42 (77.8%) lower lobe

Single/multiple lesions

8 (14.8%) single; 46 (85.2%) multiple

Ground-glass opacities

42 (77.8%)

Consolidation

12 (22.2%)

Interlobular septal thickening

11 (20.4%)

Reversed halo sign

9 (16.7%)

Air bronchogram

18 (33.3%)

Bronchial wall thickening

3 (5.6%)

Tree-in-bud pattern

1 (1.9%)

Air cavity

4 (7.4%)

Pleural thickening or pleural effusion

14 (25.9%)

Intrathoracic lymph node enlargement

2 (3.7%)